Cargando…
Comprehensive Analysis of Regulatory Networks of m6A Regulators and Reveals Prognosis Biomarkers in Sarcoma
Sarcomas are rare malignant tumors that may arise from anywhere of the body, such as bone, adipose, muscle and vascular. However, the conventional pathogenesis of sarcomas has not been found. Therefore, there is an urgent need to identify novel therapeutic strategies and improve prognosis effects fo...
Autores principales: | Pang, Boran, Luo, Dinghao, Cao, Bojun, Wu, Wen, Wang, Lei, Hao, Yongqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284210/ https://www.ncbi.nlm.nih.gov/pubmed/35847857 http://dx.doi.org/10.3389/fonc.2022.911596 |
Ejemplares similares
-
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma
por: Pang, Boran, et al.
Publicado: (2021) -
The first 3D-bioprinted personalized active bone to repair bone defects: A case report
por: Hao, Yongqiang, et al.
Publicado: (2022) -
m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients
por: Xu, Chenyang, et al.
Publicado: (2022) -
Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
por: Li, Long-Qing, et al.
Publicado: (2020) -
Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
por: Zhang, Qing, et al.
Publicado: (2023)